2026 Q1 Portfolio Activity
In 2026 Q1, DIADEMA PARTNERS LP maintained a portfolio of 220 distinct positions. The most significant new addition was BRIDGEBIO PHARMA INC, now representing 3.16% of the total fund value. They heavily accumulated shares in VERTEX PHARMACEUTICALS INC, increasing the position by 831.0%. The fund also reduced its exposure to VERTEX PHARMACEUTICALS INC by 95.7%.
Position History
hover any row below to update
Loading…
DIADEMA PARTNERS LP
AUM $224M
Total Positions
220
Quarter
2026 Q1
Top Holding
VRTX (7.1%)
Top 10 Concentration
36.5%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 220
DIADEMA PARTNERS LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VRTX
CALL
VERTEX PHARMACE...
|
CALL Option | 7.07% | 6.90% |
#1
Prev: #1
|
6.8 |
—
|
4,800 | 5.4% |
P
S
|
93,100 | $41,572,874 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LQDA
CALL
LIQUIDIA CORPOR...
|
CALL Option | 4.25% | — |
#2
Prev: #—
|
6.7 |
—
|
662,100 | — |
NEW
|
662,100 | $24,987,654 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
CALL
UNITED THERAPEU...
|
CALL Option | 4.06% | — |
#3
Prev: #—
|
6.1 |
—
|
40,200 | — |
NEW
|
40,200 | $23,837,796 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VKTX
CALL
VIKING THERAPEU...
|
CALL Option | 3.65% | 4.17% |
#4
Prev: #4
|
2.5 |
—
|
-29,700 | -4.3% |
P
S
|
659,200 | $21,450,368 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAPR
PUT
CAPRICOR THERAP...
|
PUT Option | 3.22% | 0.99% |
#5
25
Prev: #30
|
4.8 |
—
|
423,400 | 211.7% |
P
S
|
623,400 | $18,951,360 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APGE
CALL
APOGEE THERAPEU...
|
CALL Option | 3.19% | 2.74% |
#6
2
Prev: #8
|
3.3 |
—
|
11,400 | 5.4% |
P
S
|
222,500 | $18,727,825 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
BRIDGEBIO PHARM...
|
|
Bond/Debt | 3.16% | — |
#7
Prev: #—
|
4.8 |
—
|
250,000 | — |
NEW
|
250,000 | $18,565,000 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 2.91% | 2.04% |
#8
5
Prev: #13
|
4.2 |
—
|
188,332 | 55.9% |
P
S
|
525,181 | $17,089,390 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 2.75% | 0.84% |
#9
23
Prev: #32
|
4.1 |
—
|
17,303 | 173.0% |
P
S
|
27,303 | $16,190,133 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
PUT
CYTOKINETICS IN...
|
PUT Option | 2.24% | — |
#10
Prev: #—
|
4.4 |
—
|
200,000 | — |
NEW
|
200,000 | $13,182,000 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 2.24% | 2.37% |
#11
Prev: #11
|
1.4 |
—
|
-12,673 | -19.1% |
P
S
|
53,771 | $13,143,783 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.11% | 0.81% |
#12
22
Prev: #34
|
3.8 |
—
|
190,912 | 144.8% |
P
S
|
322,764 | $12,423,186 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
PUT
REVOLUTION MEDI...
|
PUT Option | 2.08% | — |
#13
Prev: #—
|
4.3 |
—
|
125,500 | — |
NEW
|
125,500 | $12,204,875 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRK
PUT
MERCK & CO INC
|
PUT Option | 2.05% | — |
#14
Prev: #—
|
4.3 |
—
|
100,000 | — |
NEW
|
100,000 | $12,029,000 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
UTHR
PUT
UNITED THERAPEU...
|
PUT Option | 2.02% | — |
#15
Prev: #—
|
4.3 |
—
|
20,000 | — |
NEW
|
20,000 | $11,859,600 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
CALL
ABIVAX SA
|
CALL Option | 1.89% | — |
#16
Prev: #—
|
4.3 |
—
|
100,000 | — |
NEW
|
100,000 | $11,135,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
PUT
ABIVAX SA
|
PUT Option | 1.89% | — |
#17
Prev: #—
|
4.3 |
—
|
100,000 | — |
NEW
|
100,000 | $11,135,000 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 1.76% | — |
#18
Prev: #—
|
4.2 |
—
|
54,755 | — |
NEW
|
54,755 | $10,351,433 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CAPR
CALL
CAPRICOR THERAP...
|
CALL Option | 1.70% | 1.55% |
#19
1
Prev: #20
|
2.7 |
—
|
17,000 | 5.4% |
P
S
|
329,300 | $10,010,720 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INCY
PUT
INCYTE CORP
|
PUT Option | 1.69% | 1.70% |
#20
2
Prev: #18
|
2.7 |
—
|
5,400 | 5.4% |
P
S
|
105,400 | $9,920,248 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TERN
TERNS PHARMACEU...
|
Healthcare | 1.63% | 2.41% |
#21
11
Prev: #10
|
0.7 |
—
|
-164,128 | -47.5% |
P
S
|
181,752 | $9,581,965 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KOD
PUT
KODIAK SCIENCES...
|
PUT Option | 1.60% | — |
#22
Prev: #—
|
4.1 |
—
|
246,900 | — |
NEW
|
246,900 | $9,411,828 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ROIV
PUT
ROIVANT SCIENCE...
|
PUT Option | 1.58% | 1.19% |
#23
3
Prev: #26
|
2.6 |
—
|
17,100 | 5.4% |
P
S
|
335,800 | $9,301,660 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 1.42% | 1.50% |
#24
3
Prev: #21
|
1.1 |
—
|
1,868 | 1.3% |
P
S
|
148,229 | $8,373,456 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 1.40% | 1.76% |
#25
8
Prev: #17
|
1.1 |
—
|
300 | 0.4% |
P
S
|
75,944 | $8,217,262 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRNA
PUT
MODERNA INC
|
PUT Option | 1.38% | — |
#26
Prev: #—
|
4.1 |
—
|
159,400 | — |
NEW
|
159,400 | $8,097,520 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 1.34% | 0.51% |
#27
19
Prev: #46
|
3.5 |
—
|
43,852 | 118.5% |
P
S
|
80,872 | $7,864,802 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 1.25% | — |
#28
Prev: #—
|
4.0 |
—
|
192,962 | — |
NEW
|
192,962 | $7,355,711 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INCY
INCYTE CORP
|
Healthcare | 1.25% | — |
#29
Prev: #—
|
4.0 |
—
|
78,029 | — |
NEW
|
78,029 | $7,344,089 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 1.17% | 0.63% |
#30
9
Prev: #39
|
3.5 |
—
|
83,645 | 67.8% |
P
S
|
206,928 | $6,874,148 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
CALL
EDGEWISE THERAP...
|
CALL Option | 1.14% | — |
#31
Prev: #—
|
4.0 |
—
|
212,500 | — |
NEW
|
212,500 | $6,693,750 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CORT
CALL
CORCEPT THERAPE...
|
CALL Option | 1.09% | — |
#32
Prev: #—
|
3.9 |
—
|
158,500 | — |
NEW
|
158,500 | $6,389,135 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 1.08% | 0.92% |
#33
2
Prev: #31
|
2.9 |
—
|
15,311 | 21.9% |
P
S
|
85,311 | $6,335,195 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GPCR
PUT
STRUCTURE THERA...
|
PUT Option | 1.05% | — |
#34
Prev: #—
|
3.9 |
—
|
127,500 | — |
NEW
|
127,500 | $6,145,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMCR
IMMUNOCORE HLDG...
|
Healthcare | 0.99% | 0.42% |
#35
18
Prev: #53
|
3.4 |
—
|
122,889 | 174.8% |
P
S
|
193,189 | $5,824,648 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 0.94% | 0.37% |
#36
25
Prev: #61
|
3.4 |
—
|
4,000 | 200.0% |
P
S
|
6,000 | $5,518,620 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ABBV
ABBVIE INC
|
Healthcare | 0.89% | — |
#37
Prev: #—
|
3.9 |
—
|
24,058 | — |
NEW
|
24,058 | $5,232,374 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 0.88% | — |
#38
Prev: #—
|
3.9 |
—
|
238,142 | — |
NEW
|
238,142 | $5,143,867 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRSP
CALL
CRISPR THERAPEU...
|
CALL Option | 0.86% | 1.02% |
#39
10
Prev: #29
|
0.8 |
—
|
-6,400 | -5.7% |
P
S
|
106,300 | $5,056,691 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
PUT
UNIQURE NV
|
PUT Option | 0.83% | 1.24% |
#40
15
Prev: #25
|
0.8 |
—
|
-2,800 | -0.9% |
P
S
|
299,000 | $4,888,650 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.70% | — |
#41
Prev: #—
|
3.8 |
—
|
439,957 | — |
NEW
|
439,957 | $4,131,196 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
QURE
CALL
UNIQURE NV
|
CALL Option | 0.70% | — |
#42
Prev: #—
|
3.8 |
—
|
250,000 | — |
NEW
|
250,000 | $4,087,500 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.61% | — |
#43
Prev: #—
|
3.7 |
—
|
244,811 | — |
NEW
|
244,811 | $3,581,585 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZYME
ZYMEWORKS INC
|
Healthcare | 0.61% | — |
#44
Prev: #—
|
3.7 |
—
|
142,132 | — |
NEW
|
142,132 | $3,558,985 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
REPL
PUT
REPLIMUNE GROUP...
|
PUT Option | 0.60% | — |
#45
Prev: #—
|
3.7 |
—
|
459,900 | — |
NEW
|
459,900 | $3,518,235 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.59% | — |
#46
Prev: #—
|
3.7 |
—
|
72,234 | — |
NEW
|
72,234 | $3,481,679 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CYTK
CALL
CYTOKINETICS IN...
|
CALL Option | 0.56% | — |
#47
Prev: #—
|
3.7 |
—
|
50,000 | — |
NEW
|
50,000 | $3,295,500 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PCVX
CALL
VAXCYTE INC
|
CALL Option | 0.53% | — |
#48
Prev: #—
|
3.7 |
—
|
53,100 | — |
NEW
|
53,100 | $3,085,641 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 0.52% | 0.17% |
#49
44
Prev: #93
|
3.2 |
—
|
125,026 | 200.7% |
P
S
|
187,307 | $3,081,200 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.49% | 0.51% |
#50
5
Prev: #45
|
0.2 |
—
|
-63,432 | -26.1% |
P
S
|
179,738 | $2,874,011 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 220 holdings